|
|
|
|
|
|
Moleculin Biotech CS (MBRX)
|
|
1.52 +0.42 (+38.18%)
|
6/26/2017 4:00pm
|
|
Open:
|
1.25
|
Pre. Close:
|
1.10
|
|
High:
|
1.52
|
Low:
|
1.10
|
|
Volume:
|
5,544,160
|
Market Cap:
|
26.99M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
-
|
-
|
|
Low:
|
-
|
-
|
|
Close:
|
-
|
-
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-26 11:34:49 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 1.78  One year: 2.07
|
|
Support:
|
Support1: 1.02 Support2: 0.71
|
|
Resistance:
|
Resistance1:
1.52 Resistance2: 1.78
|
|
Pivot:
|
0.90
|
|
Moving Averages:
|
MA(5): 1.10 MA(20): 0.88
MA(100): 1.04  MA(250): 3.08
|
|
MACD:
|
MACD(12,26):
0.09 Signal(12,26,9): 0.02
|
|
%K %D:
|
%K(14,3): 72.31 %D(3): 63.79
|
|
RSI:
|
RSI(14): 83.20
|
|
52-Week:
|
High: 7.36
Low: 0.71 Change(%): -77.8
|
|
Average Vol(K):
|
3-Month: 639
10-Days 2605
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.MBRX has closed above the upper band by 30.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 67.4% wider than normal. The large width of the bands suggest high volatility as compared to MBRX's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Thu, 02 Jun 2016 10:02:32 GMT
1.12
Mon, 26 Jun 2017 11:26:15 GMT
Moleculin Announces Scientific Support for Research Endeavor at Mayo Clinic
Wed, 21 Jun 2017 11:26:15 GMT
Moleculin Biotech (MBRX) Reports Significant Discovery with Potential to Treat ...
Wed, 28 Oct 2015 13:41:15 GMT
Moleculin Biotech, Inc. Announces Acquisition of Annamycin Rights
Thu, 22 Jun 2017 19:41:15 GMT
Checking the Overall Picture for Moleculin Biotech, Inc. (MBRX)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
